EP4065084A1 — Pharmaceutical compositions
Assigned to Douglas Pharmaceuticals Ltd · Expires 2022-10-05 · 4y expired
What this patent protects
The present invention relates to self-emulsifying pharmaceutical compositions comprising an unsaturated free fatty acid, at least two emulsifiers and at least one active pharmaceutical ingredient; to the use of said pharmaceutical compositions as a medicament; and to processes fo…
USPTO Abstract
The present invention relates to self-emulsifying pharmaceutical compositions comprising an unsaturated free fatty acid, at least two emulsifiers and at least one active pharmaceutical ingredient; to the use of said pharmaceutical compositions as a medicament; and to processes for the preparation of said compositions.
Drugs covered by this patent
- Solosec (SECNIDAZOLE) · Evofem Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.